Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Oprah reveals diabetes drug role in her weight loss journey
Oprah Winfrey admitted two years ago to taking diabetes medication to lose weight. Now, in a new podcast episode, she revealed that this process helped her understand slim people. Oprah Winfrey has struggled with weight issues for years.
Weight-Loss Drugs Like Ozempic Linked To Lower Risk Of 42 Conditions
Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took researchers by surprise.
Amy Schumer Reveals Why She Quit Ozempic Despite Dropping 30 Pounds From the Weight-Loss Drug
Amy Schumer got brutally honest about the pros and cons she experienced while taking popular weight-loss drug Ozempic. On the Wednesday, January 29, installment of The Howard Stern Show, the actress revealed she took the medication "almost three years ago.
Amy Schumer Lost 30 Lbs. on Ozempic — 'I Looked Great' — but Quit After Being ‘Bedridden’ with Nausea
Actress and comedian Amy Schumer said she took Ozempic three years ago and quickly lost 30 lbs. However, she quit the medication after the weekly injections gave her bad nausea that left her bedridden.
Amy Schumer Details 'Horrible Experience' Using Ozempic for Weight Loss
Once upon a time, Amy Schumer was one of the countless stars falling in line for the Ozempic craze, but, despite losing 30 pounds with the help of the Type 2 diabetes drug, the comedian had an overall "horrible experience" with it.
5h
Ozempic vs. Semaglutide: 10 Weight Loss Medications Compared for 2025
Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...
4d
Eli Lilly's head of obesity talks weight-loss innovations for 2025 — from an Ozempic-like pill to a triple-threat shot
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
2d
on MSN
The Health Risks and Benefits of Weight-Loss Drugs
The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...
STAT
13d
Medicare announces plan to negotiate prices of diabetes, weight loss drugs
WASHINGTON — Medicare officials announced plans to negotiate the prices of blockbuster diabetes and weight loss drugs Ozempic ...
USA Today
13d
Medicare targets popular weight loss drugs Ozempic, Wegovy for price negotiations
Medicare will seek to negotiate lower list prices for the blockbuster
diabetes
and
weight
loss
drugs
Ozempic and Wegovy and 14 other medications, a cost-saving move that would take effect in ...
8d
on MSN
Massive study looks at benefits, risks of GLP-1 weight-loss drugs
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
HealthDay on MSN
9d
Popular GLP-1 Drugs Are Shaping Health Beyond Weight Loss & Diabetes
Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions ...
4h
Cork woman, 66, died of organ failure after ‘severe vomiting’ while taking weight loss drug Ozempic, inquest told
A GRANDMOTHER died of total organ failure after severe vomiting while taking weight loss drugs Ozempic and Metformin to ...
The Lancet
6d
Estimating direct tissue effects versus weight loss effects of incretin-based drugs for obesity on various chronic conditions
The extent to which newer, incretin-based drugs for obesity improve disease outcomes via weight loss versus the direct ...
2d
on MSN
FDA approves Novo Nordisk's diabetes drug Ozempic for chronic kidney disease, expanding use in U.S.
Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback